These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21889064)

  • 1. How do you determine the quality of the evidence?
    Kokich VG
    Am J Orthod Dentofacial Orthop; 2011 Sep; 140(3):283. PubMed ID: 21889064
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials: a summary.
    Wilhelmsen L; Held P; Wedel H
    J Intern Med; 2004 Oct; 256(4):284-7. PubMed ID: 15367170
    [No Abstract]   [Full Text] [Related]  

  • 3. Planning of clinical trials.
    Boissel JP
    J Intern Med; 2004 Apr; 255(4):427-38. PubMed ID: 15049877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reading clinical research--what can we expect to learn from reading randomized clinical trials?
    Riegelman R
    Md Med; 2002; 3(1):35-8. PubMed ID: 11868492
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding statistical terms: 2.
    Drug Ther Bull; 2009 Mar; 47(3):35-6. PubMed ID: 19261839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding statistical terms: 1.
    Drug Ther Bull; 2009 Feb; 47(2):22-4. PubMed ID: 19193703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the evolution of statistical methods as applied to clinical trials.
    Machin D
    J Intern Med; 2004 May; 255(5):521-8. PubMed ID: 15078495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting quality in evidence-based studies.
    Yoon U; Knobloch K
    J Am Coll Surg; 2010 Apr; 210(4):533. PubMed ID: 20347748
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of clinical trials in secondary prevention after acute coronary syndromes.
    Bueno H; Armstrong PW; Buxton MJ; Danchin N; Lubsen J; Roland E; Verheugt FW; Zalewski A; Jackson N; Komajda M; Steg PG;
    Eur Heart J; 2011 Jul; 32(13):1583-9. PubMed ID: 21037255
    [No Abstract]   [Full Text] [Related]  

  • 10. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections, by H. Schäfer and H.-H. Müller, Statistics in Medicine 2001; 20: 3741-3751.
    Bauer P; Posch M
    Stat Med; 2004 Apr; 23(8):1333-4; author reply 1334-5. PubMed ID: 15083486
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 14. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 15. Design of adaptive two-stage double-arm clinical trials for dichotomous variables.
    Jiang Z; Xue F; Li C; Wang L; Cai H; Zhang C; Xia J
    Contemp Clin Trials; 2010 May; 31(3):242-50. PubMed ID: 20172053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials.
    Goudie AC; Sutton AJ; Jones DR; Donald A
    J Clin Epidemiol; 2010 Sep; 63(9):983-91. PubMed ID: 20573483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
    Villar J; Carroli G
    Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some main problems eroding the credibility and relevance of randomized trials.
    Ioannidis JP
    Bull NYU Hosp Jt Dis; 2008; 66(2):135-9. PubMed ID: 18537784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample sizes for cancer trials where Health Related Quality of Life is the primary outcome.
    Julious SA; Campbell MJ; Walker SJ; George SL; Machin D
    Br J Cancer; 2000 Oct; 83(7):959-63. PubMed ID: 10970702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.